MY134868A - Improved growth stimulant compositions - Google Patents

Improved growth stimulant compositions

Info

Publication number
MY134868A
MY134868A MYPI99004773A MYPI9904773A MY134868A MY 134868 A MY134868 A MY 134868A MY PI99004773 A MYPI99004773 A MY PI99004773A MY PI9904773 A MYPI9904773 A MY PI9904773A MY 134868 A MY134868 A MY 134868A
Authority
MY
Malaysia
Prior art keywords
growth stimulant
improved growth
release
improved
stimulant compositions
Prior art date
Application number
MYPI99004773A
Inventor
Shih Chung
Thomas J Kennedy
Knight Peter James
Daniel S Robins
Shao Zezhi Jesse
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MY134868A publication Critical patent/MY134868A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

AN IMPROVED WEIGHT AND GROWTH STIMULANT FOR DOMESTICATED ANIMALS SUCH AS CATTLE, PIGS AND SHEEP IS COMPRISED OF AN ANABOLIC AGENT THAT IS SUBCUTANEOUSLY ADMINISTERED IN THE FORM OF A DUAL RELEASE IMPLANT FORMULATION. INCREASED GAINS ARE PARTICULALRY IMPROVED WHEN ZERANOL IS ADMINISTERED IN AN IMMEDIATE-RELEASE AND CONTROLLED-RELEASE FORMULATION WHICH ALLOWS FOR A ONETIME DOSAGE INJECTION.
MYPI99004773A 1998-11-04 1999-11-03 Improved growth stimulant compositions MY134868A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
MY134868A true MY134868A (en) 2007-12-31

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99004773A MY134868A (en) 1998-11-04 1999-11-03 Improved growth stimulant compositions

Country Status (11)

Country Link
AR (1) AR025133A1 (en)
AU (1) AU777393B2 (en)
BR (2) BRPI9914996B8 (en)
CA (1) CA2348841C (en)
CO (1) CO5140100A1 (en)
CR (1) CR6351A (en)
MY (1) MY134868A (en)
PE (1) PE20001092A1 (en)
TW (1) TWI250027B (en)
WO (1) WO2000025743A2 (en)
ZA (1) ZA200103494B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4000688B1 (en) 2020-11-19 2025-11-05 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution
EP4001288B1 (en) 2020-11-19 2025-05-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
ES2948624T3 (en) 2020-11-19 2023-09-14 Fis Fabbrica Italiana Sintetici Spa Improved process for the preparation of trenbolone and/or trenbolone acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (en) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog EXTENDED RELEASE ANABOLIZING IMPLANTS
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
WO2000025743A3 (en) 2000-08-24
CA2348841C (en) 2007-04-17
ZA200103494B (en) 2002-07-30
BRPI9914996A (en) 2001-07-10
BRPI9914996B8 (en) 2021-07-06
CA2348841A1 (en) 2000-05-11
PE20001092A1 (en) 2000-10-31
TWI250027B (en) 2006-03-01
CO5140100A1 (en) 2002-03-22
AU3096700A (en) 2000-05-22
CR6351A (en) 2003-11-20
BRPI9914996B1 (en) 2011-11-01
BR9914996A (en) 2001-07-10
WO2000025743A2 (en) 2000-05-11
AR025133A1 (en) 2002-11-13
AU777393B2 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
BR0008590A (en) Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
DK0862416T3 (en) Non-polymeric delayed release administration system
BR0013116B1 (en) Single dose oral formulations to control ectoparasite infestation in pets, and their use.
EE9900288A (en) Use of an Oral Pharmaceutical Composition for the manufacture of a medicament for the treatment of erectile dysfunction in men
BG66093B1 (en) Controlled release compositions comprising nimesulide
MY113488A (en) Compounds with growth hormone releasing properties
ATE387430T1 (en) COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE INGREDIENTS
JP2003517014A (en) Pharmaceutical implant containing immediate release and sustained release components and administration method
NZ514323A (en) A immunostimulant containing an acitive agent and an adjuvant which increases the effect of the active agent
JP2010500975A (en) Application of initial amount of LHRH analogue and maintenance amount of LHRH antagonist for treatment of hormone-dependent cancer and corresponding pharmaceutical kit
YU2603A (en) New combination of serotonin agonist (5ht2) and antagonist (5ht6) as pharmaceutical formulation
DE69819145D1 (en) BIO-DEGRADABLE MICROPARTICLES WITH DELAYED ACTIVE SUBSTANCE RELEASE
BR9106676A (en) PEPTIDE, PROCESS TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMAL, PHARMACEUTICAL COMPOSITION TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMALS, USE OF THE COMPOUND AND PROCESS TO PROMOTE THE LIBERATION IN THE ELEVATION BLOOD
WO2000025743A3 (en) Improved growth stimulant compositions
US20010041697A1 (en) Implant composition containing melengestrol acetate and trenbolone acetate
NZ219300A (en) Veterinary composition for release of actives into the rumen
RU96103819A (en) FODDER ADDITIVE FOR YOUNG CATTLE
YU14700A (en) 8a-azalides as veterinary antimicrobial agents
PT873134E (en) AQUOSA FORMULATION OF PROLONGED LIBERATION COMPREENDING FACTOR OF LIBERATION OF HORMONE OF BOVINE GROWTH
TH48412A3 (en) Growth stimulant composition That has been updated
ECSP993205A (en) IMPROVED GROWTH STIMULATING COMPOSITIONS (CASE AHO948)
MXPA99005235A (en) Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating.
CZ309392A3 (en) Injectible veterinary preparation without side toxic effects, and process for preparing thereof
TH48412A (en) Improved growth-stimulating components.